LCE2C inhibitors are a class of chemical compounds that focus on the inhibition of the Late Cornified Envelope 2C (LCE2C) protein. This protein, a member of the Late Cornified Envelope (LCE) protein family, plays a crucial role in the formation of the cornified envelope of the epidermis. The cornified envelope is an essential component of the skin's barrier function, providing protection against environmental factors and maintaining homeostasis. The LCE2C inhibitors, through their specific interaction with the LCE2C protein, influence this process. The exact mechanism of action of these inhibitors involves binding to the LCE2C protein, thereby modulating its function. This interaction is typically characterized by a high degree of specificity, ensuring that the inhibitors primarily target the LCE2C protein with minimal effects on other proteins in the LCE family. Some inhibitors work indirectly.
The chemical structure of LCE2C inhibitors is diverse, encompassing a range of molecular frameworks. This diversity allows for varying degrees of affinity and specificity towards the LCE2C protein. The design and development of these inhibitors often involve advanced techniques in chemistry and computational modeling to optimize their interaction with the target protein. This includes the fine-tuning of their physicochemical properties, such as solubility, stability, and molecular size, to enhance their effectiveness in modulating the LCE2C protein. Moreover, the study of LCE2C inhibitors also contributes significantly to the broader understanding of skin biology, particularly in the context of the epidermal differentiation complex (EDC), where the LCE gene family is located. Research in this area not only deepens our knowledge of the molecular mechanisms underlying skin barrier formation but also sheds light on the intricate network of proteins involved in epidermal homeostasis and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calcipotriol | 112965-21-6 | sc-203537 sc-203537A | 10 mg 50 mg | $203.00 $832.00 | 4 | |
As a Vitamin D analog, Calcipotriol modulates keratinocyte proliferation and differentiation, thereby reducing LCE2C levels. | ||||||
Tazarotene | 118292-40-3 | sc-220193 | 10 mg | $103.00 | ||
A retinoid that normalizes keratinocyte differentiation, Tazarotene lowers expression of LCE2C in the epidermis. | ||||||
Corticosterone | 50-22-6 | sc-300391 sc-300391A | 100 mg 500 mg | $58.00 $110.00 | 2 | |
Corticosteroids inhibit inflammation and modulate skin cell growth, leading to decreased LCE2C expression in skin lesions. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate impedes cell proliferation in psoriatic plaques, which correlates with a reduction in LCE2C expression. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A indirectly lowers LCE2C levels by reducing keratinocyte hyperproliferation. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
FK-506 diminishes LCE2C expression by downregulating inflammatory pathways in the skin. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR signaling, which can indirectly reduce the hyperproliferative state that upregulates LCE2C. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea suppresses DNA synthesis in rapidly dividing cells, thus potentially decreasing LCE2C levels in hyperproliferative disorders. | ||||||
Salicylic acid | 69-72-7 | sc-203374 sc-203374A sc-203374B | 100 g 500 g 1 kg | $47.00 $94.00 $119.00 | 3 | |
Salicylic Acid, as a keratolytic agent, can reduce the thickness of plaques and indirectly diminish LCE2C protein expression. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod activates immune responses leading to alterations in keratinocyte function, which can reduce LCE2C levels. | ||||||